Search Within

David P Kelsen

  1. "Computational Oncology Service"
Formats
  1. Journal Article (15)
  2. Meeting Abstract (14)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (29)
  2. Center for Pancreatic Cancer Research (29)
  3. Computational Oncology Service (29)
  4. Department of Medicine (29)
  5. Epidemiology and Biostatistics (29)
  6. GSK Faculty (29)

More Groups

People
  1. Nikolaus Schultz (28)
  2. Geoffrey Ku (20)
  3. Yelena Janjigian (20)
  4. David Ilson (18)
  5. Jaclyn Hechtman (17)
  6. David Solit (16)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2022 (2)
  4. 2021 (1)
  5. 2020 (6)
  6. 2019 (9)

More Years

Publications
  1. Journal of Clinical Oncology (11)
  2. Annals of Oncology (3)
  3. Clinical Cancer Research (3)
  4. Cancer Discovery (2)
  5. Nature (2)
  6. Nature Communications (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (11)
  2. American Association for Cancer Research (5)
  3. Nature Publishing Group (4)
  4. Oxford University Press (4)
  5. Elsevier Inc. (2)
  6. American Medical Association (1)

More Publishers

Results (29)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical characteristics and outcomes of patients with metastatic colitis-associated cancer treated with EGFR inhibitors
    Meeting Abstract

    Yeh, C.; Cowley, C.; Srivastava, A.; Chatila, W. K.; Ismailgeci, D.; Chou, J. F.; Capanu, M.; Shah, M. A.; Sanchez-Vega, F.; Ganesh, K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers
    Journal Article

    Chatila, W. K.; Walch, H.; Hechtman, J. F.; Moyer, S. M.; Sgambati, V.; Faleck, D. M.; Srivastava, A.; Tang, L.; Benhamida, J.; Ismailgeci, D.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save
  • Characterizing the clinico-genomic landscape and outcomes of KRAS G12C mutated pancreas cancer
    Meeting Abstract

    Keane, F.; Park, W.; Varghese, A.; Balogun, F.; Yu, K.; El Dika, I.; Khalil, D.; Kelsen, D. P.; Reidy-Lagunes, D.; Ku, G. Y.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • BRCA mutational status shapes the stromal microenvironment of pancreatic cancer linking clusterin expression in cancer associated fibroblasts with HSF1 signaling
    Journal Article

    Shaashua, L.; Ben-Shmuel, A.; Pevsner-Fischer, M.; Friedman, G.; Levi-Galibov, O.; Nandakumar, S.; Barki, D.; Nevo, R.; Brown, L. E.; Zhang, W.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Prevalence of germline alterations on targeted tumor-normal sequencing of esophagogastric cancer
    Journal Article

    Ku, G. Y.; Kemel, Y.; Maron, S. B.; Chou, J. F.; Ravichandran, V.; Shameer, Z.; Maio, A.; Won, E. S.; Kelsen, D. P.; Ilson, D. H.; more...
    JAMA Network Open (2021)

    Fulltext@MSK | Save
  • Systemic chemotherapy for metastatic colitis-associated cancer has a worse outcome than sporadic colorectal cancer: Matched case cohort analysis
    Journal Article

    Yaeger, R.; Paroder, V.; Bates, D. D. B.; Capanu, M.; Chou, J.; Tang, L.; Chatila, W.; Schultz, N.; Hersch, J.; Kelsen, D.
    Clinical Colorectal Cancer (2020)

    Fulltext@MSK | Save
  • PD-L1 positive esophagogastric (EG) cancer is associated with distinct bacteria
    Meeting Abstract

    Maron, S. B.; Vanderbilt, C.; Sabwa, S.; Bowman, A.; Chatila, W. K.; Tang, L. H.; Strong, V. E.; Molena, D.; Jones, D. R.; Coit, D. G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Genomic methods identify homologous recombination deficiency in pancreas adenocarcinoma and optimize treatment selection
    Journal Article

    Park, W.; Chen, J.; Chou, J. F.; Varghese, A. M.; Yu, K. H.; Wong, W.; Capanu, M.; Balachandran, V.; McIntyre, C. A.; El Dika, I.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Genomic alterations in colitis-associated cancers in comparison to those found in sporadic colorectal cancer and present in precancerous dysplasia
    Meeting Abstract

    Chatila, W. K.; Walch, H. S.; Benhamida, J.; Hechtman, J. F.; Barriga, F. M.; Kundra, R.; Ismalgeci, D.; Miller, V. A.; Ganesh, K.; Faleck, D.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: An open-label, single-arm, phase 2 trial
    Journal Article

    Janjigian, Y. Y.; Maron, S. B.; Chatila, W. K.; Millang, B.; Chavan, S. S.; Alterman, C.; Chou, J. F.; Segal, M. F.; Simmons, M. Z.; Momtaz, P.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save